LAPTM4B and neoplasm: The data showed that high LAPTM4B-35 expression had a significantly negative influence on DFS in patients with HPV positive tumours (p = 0.0643 [Log Rank], p = 0.0453 [Gehan-Breslow]) (Fig. 3).